(IN BRIEF) Scientists at the Institute of Cancer Research, London, together with colleagues from TUD Dresden University of Technology, have discovered that oxidation of a single site in the protein p21 acts as a chemical switch determining whether cells keep … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ageing, BIOTEC, cancer therapy, CDK2, cell cycle, cysteine 41, Institute of Cancer Research, Jörg Mansfeld, Julia Vorhauser, Molecular Cell, oxidative modification, p21, partnership, radiotherapy resistance, Reactive oxygen species, redox proteomics, senescence, TUD Dresden University of Technology
(IN BRIEF) BioNTech will be presenting updates on multiple programs across its oncology pipeline at the European Society for Molecular Oncology (ESMO) Congress 2023. These updates include data on investigational CAR-T and ex-vivo T cell therapies, a novel ADC (antibody-drug … Read the full press release
Posted in Business, Education, Germany, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged BioNTech, BNT211, BNT325, cancer therapy, CAR-T, ESMO Congress 2023, ex-vivo T cell therapies, Prof. Özlem Türeci
Annual Shareholders’ Meeting in virtual format due to corona pandemic Siemens bids farewell to Joe Kaeser after more than 40 years at the company Total shareholder return more than doubled since Kaeser took office in 2013 Roland Busch new President … Read the full press release
Posted in Business, Germany, Management, News, Technology
Tagged cancer therapy, Cedrik Neike, CEO, Covid-19 pandemic, Dr. Simon Friedle, Florian Martens, Grazia Vittadini, Jim Hagemann Snabe, Joe Kaeser, Judith Wiese, Kasper Rørsted, Matthias Rebellius, Ralf P. Thomas, Roland Busch, shareholders, Siemens, Siemens AG, Siemens Healthineers, Varian, Vision 2020+
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?